Acadia Pharma Sells Voucher for Speedier FDA Drug Review for $150M
Acadia Pharmaceuticals committed a lot of money for rights to Daybue, which in the biotech’s hands became the first FDA-approved ...
Acadia Pharmaceuticals committed a lot of money for rights to Daybue, which in the biotech’s hands became the first FDA-approved ...
The blockbuster Novo Nordisk obesity drug Wegovy has met the main goals of a pivotal test in metabolic dysfunction steatohepatitis, ...
Of 104 reports of supply chain issues with dozens of drugs, meaningful shortages were 40% less likely to occur in ...
An experimental Alzheimer’s therapy from Roche successfully cleared a protein that’s a hallmark of the disease from patients’ brains, the ...
Malaria kills over 600,000 people a year, and as the climate warms, the potential range of the disease is growing. ...
Six months after launching with a mega-round of financing, Seaport Therapeutics has raised $225 million more to advance a lead ...
An Astellas Pharma drug designed to address a novel target has landed a highly anticipated FDA approval for a rare ...
Prescription medicines purchased in the U.S. under a controversial government discount program amounted to $63 billion in 2023, a 23.4% ...
Gilead Sciences is voluntarily withdrawing cancer drug Trodelvy from the U.S. market as a treatment for advanced cases of urothelial ...
In a new study led by Johns Hopkins Medicine, the drug RK-33 has demonstrated promise in treating breast cancer that ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.